In the dynamic world of biotechnology, Phio Pharmaceuticals Corp stands out as a beacon of innovation, particularly in the realm of cancer immunotherapy. As a company deeply rooted in the Health Care sector, Phio is dedicated to developing groundbreaking treatments that not only target cancer but also address a spectrum of other diseases. With its headquarters in the United States and a presence on the Nasdaq stock exchange, Phio Pharmaceuticals is a name that resonates with hope and progress in the medical community.

A Glimpse into Phio’s Financial Landscape

As of August 12, 2025, Phio Pharmaceuticals Corp’s stock closed at $2.19, reflecting a journey of highs and lows over the past year. The company’s shares reached a 52-week high of $9.79 on January 12, 2025, showcasing investor confidence in its innovative approaches and potential market impact. However, the path has not been without its challenges, as evidenced by a 52-week low of $0.966 on April 7, 2025. Despite these fluctuations, Phio’s market capitalization stands at approximately $10.5 million, underscoring its resilience and the ongoing interest in its mission.

Innovation at the Core

At the heart of Phio Pharmaceuticals’ mission is its commitment to cancer immunotherapy, a cutting-edge field that harnesses the body’s immune system to fight cancer. This focus not only highlights the company’s dedication to tackling one of the most daunting health challenges of our time but also positions it as a leader in the biotechnology industry. Beyond cancer, Phio is expanding its portfolio to include treatments for other diseases, demonstrating a holistic approach to healthcare innovation.

Serving the United States

Phio Pharmaceuticals Corp serves its customers across the United States, bringing its innovative treatments closer to those in need. The company’s efforts are not just about developing new therapies but also about making them accessible to a broader audience, thereby impacting lives and communities across the nation.

Looking Ahead

As Phio Pharmaceuticals continues to navigate the complexities of the biotechnology sector, its focus remains on innovation, patient care, and expanding its therapeutic offerings. With a solid foundation in cancer immunotherapy and a vision for broader healthcare solutions, Phio is poised for growth and continued impact in the years to come.

For more information about Phio Pharmaceuticals Corp and its groundbreaking work in the field of biotechnology, visit their official website at www.phiopharma.com .

In a world where healthcare challenges are ever-evolving, companies like Phio Pharmaceuticals Corp play a crucial role in shaping the future of medicine. Through dedication, innovation, and a patient-centered approach, Phio is not just a company; it’s a beacon of hope for millions.